These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22337655)

  • 61. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Riccio R; Terencio MC; Payá M
    Eur J Pharmacol; 2009 Oct; 620(1-3):112-9. PubMed ID: 19686718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2.
    de Oliveira AC; Candelario-Jalil E; Bhatia HS; Lieb K; Hüll M; Fiebich BL
    Glia; 2008 Jun; 56(8):844-55. PubMed ID: 18383341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
    Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
    Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Photo-crosslinking of proteins in intact cells reveals a dimeric structure of cyclooxygenase-2 and an inhibitor-sensitive oligomeric structure of microsomal prostaglandin E2 synthase-1.
    Hétu PO; Ouellet M; Falgueyret JP; Ramachandran C; Robichaud J; Zamboni R; Riendeau D
    Arch Biochem Biophys; 2008 Sep; 477(1):155-62. PubMed ID: 18498757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
    Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
    Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages.
    Díaz-Muñoz MD; Osma-García IC; Cacheiro-Llaguno C; Fresno M; Iñiguez MA
    Cell Signal; 2010 Oct; 22(10):1427-36. PubMed ID: 20546888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is mPGES-1 a promising target for pain therapy?
    Scholich K; Geisslinger G
    Trends Pharmacol Sci; 2006 Aug; 27(8):399-401. PubMed ID: 16815559
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2 , cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1.
    Ahmad W; Kumolosasi E; Jantan I; Bukhari SN; Jasamai M
    Chem Biol Drug Des; 2014 Jun; 83(6):670-81. PubMed ID: 24406103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter.
    Liu C; Chen S; Wang X; Chen Y; Tang N
    Biochem Pharmacol; 2014 Oct; 91(3):337-47. PubMed ID: 25108236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors.
    He S; Lai L
    J Chem Inf Model; 2011 Dec; 51(12):3254-61. PubMed ID: 22077876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell lines.
    Sandee D; Sivanuntakorn S; Vichai V; Kramyu J; Kirtikara K
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):111-6. PubMed ID: 19114118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel human mPGES-1 inhibitors identified through structure-based virtual screening.
    Hamza A; Zhao X; Tong M; Tai HH; Zhan CG
    Bioorg Med Chem; 2011 Oct; 19(20):6077-86. PubMed ID: 21920764
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability.
    Gordon LJ; Allen M; Artursson P; Hann MM; Leavens BJ; Mateus A; Readshaw S; Valko K; Wayne GJ; West A
    J Biomol Screen; 2016 Feb; 21(2):156-64. PubMed ID: 26336900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Continuous spectrophotometric assay amenable to 96-well plate format for prostaglandin E synthase activity.
    David Percival M
    Anal Biochem; 2003 Feb; 313(2):307-10. PubMed ID: 12605868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening.
    Bretschneider T; Ozbal C; Holstein M; Winter M; Buettner FH; Thamm S; Bischoff D; Luippold AH
    SLAS Technol; 2019 Aug; 24(4):386-393. PubMed ID: 30698995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of key residues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1.
    Pawelzik SC; Uda NR; Spahiu L; Jegerschöld C; Stenberg P; Hebert H; Morgenstern R; Jakobsson PJ
    J Biol Chem; 2010 Sep; 285(38):29254-61. PubMed ID: 20605783
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a Novel Label-Free and High-Throughput Arginase-1 Assay Using Self-Assembled Monolayer Desorption Ionization Mass Spectrometry.
    Scholle MD; Gurard-Levin ZA
    SLAS Discov; 2021 Jul; 26(6):775-782. PubMed ID: 33754845
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib.
    Jin Y; Smith CL; Hu L; Campanale KM; Stoltz R; Huffman LG; McNearney TA; Yang XY; Ackermann BL; Dean R; Regev A; Landschulz W
    Clin Pharmacol Ther; 2016 Mar; 99(3):274-84. PubMed ID: 26351780
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System.
    Greenhough LA; Clarke G; Phillipou AN; Mazani F; Karamshi B; Rowe S; Rowland P; Messenger C; Haslam CP; Bingham RP; Craggs PD
    SLAS Discov; 2021 Jun; 26(5):663-675. PubMed ID: 33783261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.